News

Tramadol ER has been approved for the treatment of moderate to moderately severe chronic pain in once-daily 100mg, 200mg and 300mg dosage strengths. Biovail is the first and

PRO 140 is a humanized monoclonal antibody against CCR5 that is designed to protect healthy immune system cells from infection by HIV, the causative agent of AIDS. Binding

Exubera is a form of insulin that is inhaled through the mouth into the lungs prior to eating, using a proprietary inhalation device and powdered insulin formulation developed

The collaboration will include the continued development of a new formulation of Intal utilizing hydrofluoroalkane (HFA), an environmentally friendly propellant. King and Inyx will co-market Intal and Tilade

This bystander effect occurs when the therapeutic protein binds to certain receptors on nearby cancer cells. This activity in breast cancer cells is another mechanism by which INGN

Under the terms of the agreement, MedImmune will be responsible for the clinical development and commercialization of any resulting products. VasGene will provide research and development support and

The investigation has been useful in establishing a maximum tolerated dose for GCS-100 and providing safety and pharmacokinetic data that supports the company’s blood-borne cancer programs. Furthermore, of

In the study, the drug was well-tolerated, stimulated immune T-cells that can attack AIDS virus-infected cells, and produced potent antibody responses with neutralizing activity against multiple HIV viral

Sanctura XR is the once-daily formulation of Sanctura, which is currently being marketed in the US. Esprit Pharma is co-promoting the treatment with Indevus and has agreed to